Subscribe to Newsletter
Discovery & Development Business Practice, Drug Delivery, Ingredients, Formulation, Dosage Forms, Technology and Equipment, Analytical Science, Trends & Forecasts

Investigating the deagglomeration profiles of dry powder inhaler formulations

Despite being an increasingly popular method of inhaled drug delivery, dry powder inhalers (DPIs) have relatively low effectiveness in delivery of the active ingredient.  Research from Monash University highlights the value of using a Spraytec laser diffraction particle size analyzer to generate powder de-agglomeration profiles which show how dose dispersion changes as a function of the applied air flow rate.  This allows efficient comparison of the dispersion performance of different formulations in a device, supporting the efficient matching of devices to formulations.

Receive content, products, events as well as relevant industry updates from The Medicine Maker and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine